首页> 外文期刊>American journal of Alzheimer's disease and other dementias >Concordance Between C-11-PIB-PET and Clinical Diagnosis in a Memory Clinic
【24h】

Concordance Between C-11-PIB-PET and Clinical Diagnosis in a Memory Clinic

机译:C-11-PIB-PET与记忆库临床诊断之间的一致性

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Today, ligands that bind to fibrillar -amyloid are detectable by Positron Emission Tomography (PET) allowing for in vivo visualization for Abeta burden. However, amyloid plaques detection per se does not establish Alzheimer's Disease diagnosis. In this sense, the utility of amyloid imaging to improve clinical diagnosis was settled only for specific clinical scenarios and few studies have assessed amyloid molecular neuroimaging in a broader clinical setting. The aim of this study is to determine the frequency of PiB amyloid findings in different diagnostic syndromes grouped into high and low probability pre- test categories, taking into account pre-test clinical assumption of the presence of AD related pathology.
机译:简介:今天,可通过正电子发射断层扫描(PET)检测与原纤维淀粉样蛋白结合的配体,从而在体内可视化Abeta负担。然而,淀粉样蛋白斑的检测本身不能建立阿尔茨海默氏病的诊断。从这个意义上讲,淀粉样蛋白成像改善临床诊断的效用仅针对特定的临床情况而定,很少有研究在更广泛的临床环境中评估淀粉样蛋白分子神经影像。这项研究的目的是在考虑到AD相关病理的存在的测试前临床假设的基础上,确定在分为高概率和低概率预测试类别的不同诊断综合征中PiB淀粉样蛋白发现的频率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号